Standout Papers

Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a sin... 2019 2026 2021 2023 252
  1. Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial (2019)
    Breelyn A. Wilky, Matteo Trucco et al. The Lancet Oncology

Immediate Impact

3 by Nobel laureates 53 standout
Sub-graph 1 of 24

Citing Papers

Tailoring traditional Chinese medicine in cancer therapy
2025 Standout
Pancreatic cancer
2025 Standout
3 intermediate papers

Works of Vaia Florou being referenced

Treatment outcomes in recurrent versus de novo metastatic pancreatic adenocarcinoma: a real world study
2022
Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort
2020
and 1 more

Author Peers

Author Last Decade Papers Cites
Vaia Florou 626 485 65 204 55 768
Elsa Kalbacher 418 437 52 181 67 800
Isabelle Laure Ray-Coquard 597 226 54 127 108 798
J. Fra 638 521 47 109 39 890
Maria Marples 500 350 41 103 30 700
Esma Saâda 370 484 76 93 70 821
Hanna Koseła-Paterczyk 407 415 86 128 71 739
Franchette W.P.J. van den Berkmortel 365 164 120 123 55 732
Jakob M. Riedl 541 254 150 63 43 790
Bernies van der Hiel 373 145 98 125 55 896
Roman Groisberg 418 371 158 56 49 695

All Works

Loading papers...

Rankless by CCL
2026